Back to search
Sporadic Amyotrophic Lateral Sclerosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Sporadic Amyotrophic Lateral Sclerosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Sporadic Amyotrophic Lateral Sclerosis trials you may qualify forThis study is a placebo-controlled Phase I study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the antisense oligonucleotide (…
The purpose of this study is to evaluate how well LY4256984 is tolerated and what side effects may occur in participants with sporadic amyotrophic lateral scler…
This is a randomized double-blind controlled exploratory clinical study to evaluate the efficacy and safety of FB1006 in the treatment of amyotrophic lateral sc…
The main purpose of this study is to assess the long-term safety and tolerability of LY4256984 in participants with Amyotrophic Lateral Sclerosis (ALS). This st…
RNALS is a multicentre, transversal, diagnostic and non-interventional study carried out in ALS reference centers; in order to identify a diagnostic signature f…
The primary purpose of this study is to evaluate the safety and tolerability of VRG50635 in participants with ALS.